Data supplements
Data Supplement
In this issue
Jump to section
Related Articles
Cited By...
- Influenza vaccination: protecting the most vulnerable
- Recommendations for Prevention and Control of Influenza in Children, 2020-2021
- Recommendations for Prevention and Control of Influenza in Children, 2019-2020
- Recommendations for Prevention and Control of Influenza in Children, 2019-2020
- When "B" becomes "A": the emerging threat of influenza B virus
- Development of Influenza B Universal Vaccine Candidates Using the "Mosaic" Hemagglutinin Approach
- Antibody Responses toward the Major Antigenic Sites of Influenza B Virus Hemagglutinin in Mice, Ferrets, and Humans
- Recommendations for Prevention and Control of Influenza in Children, 2018-2019
- A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza B Virus Monoclonal Antibody, MHAB5553A, in Healthy Volunteers
- Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model